Genetic Basis for Sleep Regulation and Sleep Disorders

ABSTRACT

Sleep disorders arise by an interaction between the environment and the genetic makeup of the individual but the relative contribution of nature and nurture varies with diseases. At one extreme are the disorders with simple Mendelian patterns of inheritance such as familial advanced sleep phase syndrome, and at the other extreme are diseases such as insomnia, which can be associated with a multitude of medical and psychiatric conditions. In this article, we review data on the relative contribution of genetic and environmental factors in the pathogenesis of various sleep disorders. The understanding of many of these disorders has been advanced by the study of sleep and circadian rhythms in model laboratory organisms. We summarize this model system research and how it relates to human sleep disorders. The current challenge in this field is the identification of susceptibility genetic loci for complex diseases such as obstructive sleep apnea. We anticipate such identification will increase our ability to assess risk for disease before symptom onset and by doing so will shift the focus from treatment to prevention of disease.

Sleep - genetics - circadian - homeostatic

REFERENCES

• 1 Peirson S, Foster R G. Melanopsin: another way of signaling light.  Neuron. 2006;  49 331-339
• 2 Hara R, Wan K, Wakamatsu H et al.. Restricted feeding entrains liver clock without participation of the superchiasmatic nucleus.  Genes Cells. 2001;  6 269-278
• 3 Konopka R J, Benzer S. Clock mutants of Drosophila melanogaster .  Proc Natl Acad Sci USA. 1971;  68 2112-2116
• 4 Allada R, Emery P, Takahashi J S, Roshbash M. Stopping time: the genetics of fly and mouse circadian clocks.  Annu Rev Neurosci. 2001;  24 1091-1119
• 5 Toh K L, Jones C R, He Y et al.. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome.  Science. 2001;  291 1040-1043
• 6 Jones C R, Campbell S S, Zone S E et al.. Familial advanced sleep-phase syndrome: a short-period circadian rhythm variant in humans.  Nat Med. 1999;  5 1062-1065
• 7 Carpen J D, Archer S N, Skene D J, Smits M, von Schantz M. A single-nucleotide polymorphism in the 5′-untranslated region of the hPER2 gene is associated with diurnal preference.  J Sleep Res. 2005;  14 293-297
• 8 Xu Y, Padiath Q S, Shapiro R E et al.. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome.  Nature. 2005;  434 640-644
• 9 Czeisler C A, Duffy J F, Shanahan T L. Stability, precision, and near 24-hour period of the human circadian pacemaker.  Science. 1999;  284 2177-2181
• 10 Dagan Y, Eisenstein M. Circadian rhythm sleep disorders: toward a more precise definition and diagnosis.  Chronobiol Int. 1999;  16 213-222
• 11 Fukuda K. Twins under shift work: a case study of sleep log data.  Percept Mot Skills. 1997;  84 931-937
• 12 Ancoli-Israel S, Schnierow B, Kelsoe J, Fink R. A pedigree of one family with delayed sleep phase syndrome.  Chronobiol Int. 2001;  18 831-840
• 13 Horne J A, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms.  Int J Chronobiol. 1976;  4 97-110
• 14 Katzenberg D, Young T, Finn L et al.. A CLOCK polymorphism associated with human diurnal preference.  Sleep. 1998;  21 569-576
• 15 Robilliard D L, Archer S N, Arendt J et al.. The 3111 Clock gene polymorphism is not associated with sleep and circadian rhythmicity in phenotypically characterized human subjects.  J Sleep Res. 2002;  11 305-312
• 16 Ebisawa T, Uchiyama M, Kajimura N et al.. Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome.  EMBO Rep. 2001;  2 342-346
• 17 Klein T, Martens H, Jan Dijk D K et al.. Circadian sleep regulation in the absence of light perception: chronic non-24-hour circadian rhythm sleep disorder in a blind man with a regular 24-hour sleep-wake schedule.  Sleep. 1993;  16 333-343
• 18 Czeisler C A. Commentary: evidence for melatonin as a circadian phase-shifting agent.  J Biol Rhythms. 1997;  12 618-623
• 19 Sack R L, Brandes R W, Kendall A R, Lewy A J. Entrainment of free-running circadian rhythms by melatonin in blind people.  N Engl J Med. 2000;  343 1070-1077
• 20 Hohjoh H, Takasu M, Shishikura K. Significant association of the arylalkylamine N-acetyltransferase (AA-NAT) gene with delayed sleep phase syndrome.  Neurogenetics. 2003;  4 151-153
• 21 Borbely A A, Achermann P. Sleep homeostasis and models of sleep regulation.  J Biol Rhythms. 1999;  14 557-568
• 22 Van Dongen H P, Baynard M D, Maislin G, Dinges D F. Systematic interindividual differences in neurobehavioral impairment from sleep loss: evidence of trait-like differential vulnerability.  Sleep. 2004;  27 423-433
• 23 Leproult R, Colecchia E F, Berardi A M, Stickgold R, Kosslyn S M, Van Cauter E. Individual differences in subjective and objective alertness during sleep deprivation are stable and unrelated.  Am J Physiol Regul Integr Comp Physiol. 2003;  284 R280-R290
• 24 Franken P, Chollet D, Tafti M. The homeostatic regulation of sleep need is under genetic control.  J Neurosci. 2001;  21 2610-2621
• 25 Hendricks J C, Finn S M, Panckeri K A et al.. Rest in Drosophila is a sleep-like state.  Neuron. 2000;  25 129-138
• 26 Shaw P J, Cirelli C, Greenspan R J, Tononi G. Correlates of sleep and waking in Drosophila melanogaster .  Science. 2000;  287 1834-1837
• 27 Hendricks J C, Kirk D, Panckeri K, Miller M S, Pack A I. Modafinil maintains waking in the fruit fly Drosophila melanogaster .  Sleep. 2003;  26 139-146
• 28 Hendricks J C, Williams J A, Panckeri K et al.. A non-circadian role for cAMP signaling and CREB activity in Drosophila rest homeostasis.  Nat Neurosci. 2001;  4 1108-1115
• 29 Graves L A, Hellman K, Veasey S, Blendy J A, Pack A I, Abel T. Genetic evidence for a role of CREB in sustained cortical arousal.  J Neurophysiol. 2003;  90 1152-1159
• 30 Cirelli C, Bushey D, Hill S et al.. Reduced sleep in Drosophila Shaker mutants.  Nature. 2005;  434 1087-1092
• 31 Pitman J L, McGill J J, Keegan K P, Allada R. A dynamic role for the mushroom bodies in promoting sleep in Drosophila .  Nature. 2006;  441 753-756
• 32 Joiner W J, Crocker A, White B H, Sehgal A. Sleep in Drosophila is regulated by adult mushroom bodies.  Nature. 2006;  441 757-760
• 33 Hori A, Hirose G. Twin studies on parasomnias.  Proceedings of the World Federation of Sleep Research Societies. 1995;  324 24A
• 34 Roth B, Buuhova S, Berkova L. Familial sleep paralysis.  Schweiz Arch Neurol Neurochir Psychiatr. 1968;  102 321-330
• 35 Goode G B. Sleep paralysis.  Arch Neurol. 1962;  6 228-234
• 36 Mignot E. Genetic and familial aspects of narcolepsy.  Neurology. 1998;  50 s16-s22
• 37 Scammell T E. The frustrating and mostly fruitless search for an autoimmune cause for narcolepsy.  Sleep. 2006;  29 601-602
• 38 Lin L, Faraco J, Li R et al.. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.  Cell. 1999;  98 365-376
• 39 Peyron C, Tighe D K, van den Pol A N et al.. Neurons containing hypocretin (orexin) project to multiple neuronal systems.  J Neurosci. 1998;  18 9996-10015
• 40 Chemelli R M, Willie J T, Sinton C et al.. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.  Cell. 1999;  98 437-451
• 41 Nishino S, Ripley B, Overeem S, Lammers G J, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy.  Lancet. 2000;  355 39-40
• 42 Peyron C, Faraco J, Rogers W et al.. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.  Nat Med. 2000;  6 991-997
• 43 Thannickal T C, Moore R Y, Nienhuis R et al.. Reduced number of hypocretin neurons in human narcolepsy.  Neuron. 2000;  27 469-474
• 44 Crocker A, Espana R A, Papadopoulou M et al.. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.  Neurology. 2005;  65 1184-1188
• 45 Mignot E, Lammers G J, Ripley B et al.. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.  Arch Neurol. 2002;  59 1553-1562
• 46 Mignot E, Hayduk R, Black J, Grumet F C, Guilleminault C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.  Sleep. 1997;  20 1012-1020
• 47 Dauvilliers Y, Carlander B, Molinari N et al.. Month of birth as a risk factor for narcolepsy.  Sleep. 2003;  26 663-665
• 48 Saper C B, Chou T C, Scammell T E. The sleep switch: hypothalamic control of sleep and wakefulness.  Trends Neurosci. 2001;  24 726-731
• 49 Lu J, Sherman D, Devor M, Saper C B. A putative flip-flop switch for control of REM sleep.  Nature. 2006;  441 589-594
• 50 Broughton R. NREM parasomnias. In: Kryger MH, Roth T, Dement WC Principles and Practice of Sleep Medicine. Philadelphia; W.B. Saunders 2000: 693-706
• 51 Fisher C, Kahn E, Edwards A, Davis D M. A psychophysiological study of nightmares and night terrors: I. Physiological aspects of the stage 4 night terror.  J Nerv Ment Dis. 1973;  157 75-98
• 52 Mahowald M. Arousal and sleep-wake transition parasomnias. In: Lee-Chiong TL, Mahowald MW, Carskadon MA Sleep Medicine. Philadelphia; Hanley and Belfus 2002: 207-213
• 53 Rosen G M, Ferber R, Mahowald M W. Evaluation of parasomnias in children.  Child Adolesc Psychiatr Clin N Am. 1996;  5 601-616
• 54 Mason II T B, Pack A I. Sleep terrors in childhood.  J Pediatr. 2005;  147 388-392
• 55 Hallstrom T. Night terror in adults through three generations.  Acta Psychiatr Scand. 1972;  48 350-352
• 56 Kales A, Soldatos C R, Bixler E O et al.. Hereditary factors in sleepwalking and night terrors.  Br J Psychiatry. 1980;  137 111-118
• 57 Ooki S. Statistical genetic analysis of some problem behaviors during sleep in childhood: estimation of genetic and environmental factors influencing multiple health phenomena simultaneously.  Nippon Eiseigaku Zasshi. 2000;  55 489-499
• 58 Lecendreux M, Bassetti C, Dauvilliers Y, Mayer G, Neidhart E, Tafti M. HLA and genetic susceptibility to sleepwalking.  Mol Psychiatry. 2003;  8 114-117
• 59 Hublin C, Kaprio J, Partinen M, Heikkila K, Koskenvuo M. Prevalence and genetics of sleepwalking: a population-based twin study.  Neurology. 1997;  48 177-181
• 60 Mahowald M W, Schenck C H, Rosen G M, Hurwitz T D. The role of a sleep disorder center in evaluating sleep violence.  Arch Neurol. 1992;  49 604-607
• 61 Owens J, Spirito A, Nobile C, Arrigan M. Incidence of parasomnias in children with obstructive sleep apnea.  Sleep. 1997;  20 1193-1196
• 62 Goodwin J L, Kaemingk K L, Fregosi R F et al.. Parasomnias and sleep disordered breathing in Caucasian and Hispanic children: the Tucson children's assessment of sleep apnea study.  BMC Med. 2004;  2 14
• 63 Guilleminault C, Palombini L, Pelayo R, Chervin R D. Sleepwalking and sleep terrors in prepubertal children: what triggers them?.  Pediatrics. 2003;  111 e17-e25
• 64 Schenck C H, Mahowald M W. Rapid eye movement sleep parasomnias.  Neurol Clin. 2005;  23 1107-1126
• 65 Schenck C H, Bundlie S R, Ettinger M G, Mahowald M W. Chronic behavioral disorders of human REM sleep: a new category of parasomnia.  Sleep. 1986;  9 293-308
• 66 Sheldon S H. Parasomnias in childhood.  Pediatr Clin North Am. 2004;  51 69-88
• 67 Montagna P. Sleep-related non epileptic motor disorders.  J Neurol. 2004;  251 781-794
• 68 Postuma R B, Lang A E, Massicotte-Marquez J, Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder.  Neurology. 2006;  66 845-851
• 69 Gagnon J F, Postuma R B, Mazza S, Doyon J, Montplaisir J. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases.  Lancet Neurol. 2006;  5 424-432
• 70 Hendricks J C, Morrison A R, Mann G L. Different behaviors during paradoxical sleep without atonia depend on pontine lesion site.  Brain Res. 1982;  239 81-105
• 71 Schenck C H, Bundlie S R, Mahowald M W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.  Neurology. 1996;  46 388-393
• 72 Boeve B F, Silber M H, Ferman T J, Lucas J A, Parisi J E. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.  Mov Disord. 2001;  16 622-630
• 73 Schapira A H. Etiology of Parkinson's disease.  Neurology. 2006;  66(suppl 4) S10-S23
• 74 Ekbom K A. Restless legs: a clinical study.  Acta Med Scand. 1945;  158 1-123
• 75 Phillips B, Young T, Finn L, Asher K, Hening W A, Purvis C. Epidemiology of restless leg syndrome in adults.  Arch Intern Med. 2000;  160 2137-2141
• 76 Lavigne G J, Montplaisir J. Restless legs syndrome and sleep bruxism.  Sleep. 1994;  17 739-743
• 77 Rothdach A J, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly.  Neurology. 2000;  54 1064-1068
• 78 Walters A S. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group.  Mov Disord. 1995;  10 634-642
• 79 Allen R P, Picchietti D L, Hening W A, Trenkwalder C, Walters A S, Montplaisir J. Restless leg syndrome diagnostic criteria, special considerations, and epidemiology. A report from the restless leg syndrome diagnosis and epidemiology workshop at the National Institutes of Health.  Sleep Med. 2003;  4 101-119
• 80 Desautels A, Turecki G, Montplaisir J et al.. Restless legs syndrome: confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity.  Arch Neurol. 2005;  62 591-596
• 81 Ekbom K A. Restless legs syndrome.  Neurology. 1960;  10 868-873
• 82 Sun E R, Chen C A, Ho G, Earley C J, Allen R P. Iron and the restless legs syndrome.  Sleep. 1998;  21 371-377
• 83 Goodman J D, Brodie C, Ayida G A. Restless leg syndrome in pregnancy.  BMJ. 1988;  297 1101-1102
• 84 Connor J R, Boyer P J, Menzies S L et al.. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome.  Neurology. 2003;  61 304-309
• 85 Allen R P, Barker P B, Wehrl F, Song H K, Earley C J. MRI measurement of brain iron in patients with restless legs syndrome.  Neurology. 2001;  56 263-265
• 86 Earley C J, Connor J R, Beard J L, Malecki E A, Epstein D K, Allen R P. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome.  Neurology. 2000;  54 1698-1700
• 87 Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J. CSF iron, ferritin and transferrin levels in restless legs syndrome.  J Sleep Res. 2005;  14 43-47
• 88 Nordlander N B. Therapy in restless legs.  Acta Med Scand. 1953;  145 453-457
• 89 Earley C J, Heckler D, Allen R P. Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome.  Sleep Med. 2005;  6 301-305
• 90 Sowers J R, Vlachakis N. Circadian variation in plasma dopamine levels in man.  J Endocrinol Invest. 1984;  7 341-345
• 91 Weber M, Lauterburg T, Tobler I, Burgunder J M. Circadian patterns of neurotransmitter related gene expression in motor regions of the rat brain.  Neurosci Lett. 2004;  358 17-20
• 92 Clemens S, Sawchuk M A, Hochman S. Reversal of the circadian expression of tyrosine hydroxylase but not nitric oxide synthase levels in the spinal cord of dopamine D(3) knockout mice.  Neuroscience. 2005;  133 353-357
• 93 Bara-Jimenez W, Aksu M, Graham B, Sato S, Hallett M. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex.  Neurology. 2000;  54 1609-1616
• 94 Lu J, Jhou T C, Saper C B. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter.  J Neurosci. 2006;  26 193-202
• 95 Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS).  Sleep Med. 2004;  5 385-391
• 96 Desautels A, Turecki G, Montplaisir J et al.. Dopaminergic neurotransmission and restless leg syndrome: a genetic association study.  Neurology. 2001;  57 1304-1306
• 97 Ambrosetto C, Lugaresi E, Coccagna G, Tasssinari C A. Clinical and polygraphic remarks in the syndrome of restless legs.  Riv Patol Nerv Ment. 1965;  86 244-252
• 98 Bornstein B. Restless legs.  Psychiatria et Neurologia. 1961;  141 165-201
• 99 Montagna P, Coccagna G, Ciriguotta F, Luganesi E. Familial restless legs syndrome. In: Guilleminault C, Lugaresi E Sleep/Wake Disorders: Natural History, Epidemiology, and Long-Term Evolution. New York; Raven Press 1983: 231-235
• 100 Hening W A, Washburn T, Somel D, LeSage S, Allen R P, Earley C J. RLS patients with younger age of onset have a higher frequency of affected relatives.  Neurology. 2003;  60(suppl 1) S05.004
• 101 Ondo W G, Vuong K D, Wang Q. Restless leg syndrome in monozygotic twins: clinical correlates.  Neurology. 2000;  55 1404-1406
• 102 Trenkwalder C, Seidel V C, Gasser T, Oertel W H. Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome.  Mov Disord. 1996;  11 389-394
• 103 Lazzarini A, Walters A S, Hickey K et al.. Studies of penetrance and anticipation in five autosomal-dominant restless legs syndrome pedigrees.  Mov Disord. 1999;  14 111-116
• 104 Winkelmann J, Muller-Myhsok B, Wittchen H U et al.. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families.  Ann Neurol. 2002;  52 297-302
• 105 Desautels A, Turecki G, Montplaisir J, Saqueira A, Verner A, Rouleau G A. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q.  Am J Hum Genet. 2001;  69 1266-1270
• 106 Walters A S, Picchietti D L, Hening W A, Lazzarini A. Variable expressivity in familial restless leg syndrome.  Arch Neurol. 1990;  47 1219-1220
• 107 Kock N, Culjkovic B, Maniak S et al.. Mode of inheritance and susceptibility locus for restless legs syndrome, on chromosome 12q.  Am J Hum Genet. 2002;  71 205-208
• 108 Bonati M T, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G. Autosomal dominant restless legs syndrome maps to chromosome 14q.  Brain. 2003;  126 1485-1492
• 109 Chen S, Ondo W G, Rao S, Li L, Chen Q, Wang Q. Genomewide linkage scan identifies a novel susceptibility locus for restless leg syndrome on chromosome 9p.  Am J Hum Genet. 2004;  74 876-885
• 110 Desautels A, Turecki G, Montplaisir J et al.. Evidence for a genetic association between monoamine oxidase A and restless leg syndrome.  Neurology. 2002;  59 215-219
• 111 Gemignani F, Marbini A, Di Giovanni G, Salih S, Terzano M G. Charcot-Marie-Tooth disease type 2 with restless legs syndrome.  Neurology. 1999;  52 1064-1066
• 112 Konieczny M, Bauer P, Tomiuk J et al.. CAG repeats in restless legs syndrome.  Am J Med Genet B Neuropsychiatr Genet. 2006;  141 173-176
• 113 Roth T. Prevalence, associated risks, and treatment patterns of insomnia.  J Clin Psychiatry. 2005;  66(suppl 9) 10-13
• 114 Stepanski E J, Rybarczyk B. Emerging research on the treatment and etiology of secondary or comorbid insomnia.  Sleep Med Rev. 2006;  10 7-18
• 115 Fava M. Daytime sleepiness and insomnia as correlates of depression.  J Clin Psychiatry. 2004;  65(suppl 16) 27-32
• 116 Dauvilliers Y, Morin C, Cervena K et al.. Family studies in insomnia.  J Psychosom Res. 2005;  58 271-278
• 117 Gambetti P, Parchi P. Insomnia in prion diseases: sporadic and familial.  N Engl J Med. 1999;  340 1675-1677
• 118 Prusiner S B. Prions.  Proc Natl Acad Sci USA. 1998;  95 13363-13383
• 119 Dauvilliers Y, Cervena K, Carlander B et al.. Dissociation in circadian rhythms in a pseudohypersomnia form of fatal familial insomnia.  Neurology. 2004;  63 2416-2418
• 120 Lugaresi E, Medori R, Baruzzi A et al.. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei.  N Engl J Med. 1986;  315 997-1003
• 121 Manetto V, Medori R, Cortelli P et al.. Fatal familial insomnia: clinical and pathologic study of 5 new cases.  Neurology. 1992;  42 312-319
• 122 Goldfarb L G, Petersen R B, Tabaton M et al.. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism.  Science. 1992;  258 806-808
• 123 Montagna P, Cortelli P, Avoni P et al.. Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene.  Brain Pathol. 1998;  8 515-520
• 124 Mastrianni J A, Nixon R, Layzer R et al.. Prion protein conformation in a patient with sporadic fatal insomnia.  N Engl J Med. 1999;  340 1630-1638
• 125 Parchi P, Capellari S, Chin S et al.. A subtype of sporadic prion disease mimicking fatal familial insomnia.  Neurology. 1999;  52 1757-1763
• 126 Landolt H P, Glatzel M, Blattler T et al.. Sleep-wake disturbances in sporadic Creutzfeldt-Jakob disease.  Neurology. 2006;  66 1418-1424
• 127 Tobler I, Deboer T, Fischer M. Sleep and sleep regulation in normal and prion protein-deficient mice.  J Neurosci. 1997;  17 1869-1879
• 128 Bazil C W. Nocturnal seizures.  Semin Neurol. 2004;  24 293-300
• 129 Herman S T, Walczak T S, Bazil C W. Distribution of partial seizures during the sleep-wake cycle: differences by seizure onset site.  Neurology. 2001;  56 1453-1459
• 130 Malow B A, Weatherwax K J, Chervin R D et al.. Identification and treatment of obstructive sleep apnea in adults and children with epilepsy: a prospective pilot study.  Sleep Med. 2003;  4 509-515
• 131 Malow B A. Sleep deprivation and epilepsy.  Epilepsy Curr. 2004;  4 193-195
• 132 Vadlamudi L, Kjeldsen M J, Corey L A et al.. Analyzing the etiology of benign Rolandic epilepsy: a multicenter twin collaboration.  Epilepsia. 2006;  47 550-555
• 133 Provini F, Plazzi G, Tinuper P, Vandi S, Lugaresi E, Montagna P. Nocturnal frontal lobe epilepsy: a clinical and polygraphic overview of 100 consecutive cases.  Brain. 1999;  122 1017-1031
• 134 Provini F, Plazzi G, Lugaresi E. From nocturnal paroxysmal dystonia to nocturnal frontal lobe epilepsy.  Clin Neurophysiol. 2000;  111(suppl 2) S2-S8
• 135 Hirose S, Iwata H, Akiyoshi H et al.. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy.  Neurology. 1999;  53 1749-1753
• 136 De Fusco M, Becchetti A, Patrignani A et al.. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy.  Nat Genet. 2000;  26 275-276
• 137 Bertrand D, Picard F, Le Hellard S et al.. How mutations in the nAChRs can cause ADNFLE epilepsy.  Epilepsia. 2002;  43(suppl 5) 112-122
• 138 Combi R, Dalpra L, Ferini-Strambi L, Tenchini M L. Frontal lobe epilepsy and mutations of the corticotropin-releasing hormone gene.  Ann Neurol. 2005;  58 899-904
• 139 Pack A I. Advances in sleep-disordered breathing.  Am J Respir Crit Care Med. 2006;  173 7-15
• 140 Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults.  N Engl J Med. 1993;  328 1230-1235
• 141 Young T, Peppard P E, Gottlieb D J. Epidemiology of obstructive sleep apnea: a population health perspective.  Am J Respir Crit Care Med. 2002;  165 1217-1239
• 142 Young T, Skatrud J, Peppard P E. Risk factors for obstructive sleep apnea in adults.  JAMA. 2004;  291 2013-2016
• 143 Bixler E O, Vgontzas A N, Lin H M et al.. Prevalence of sleep-disordered breathing in women: effects of gender.  Am J Respir Crit Care Med. 2001;  163 608-613
• 144 Peppard P E, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing.  JAMA. 2000;  284 3015-3021
• 145 Pepperell J C, Ramdassingh-Dow S, Crosthwaite N et al.. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial.  Lancet. 2002;  359 204-210
• 146 Becker H F, Jerrentrup A, Ploch T et al.. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea.  Circulation. 2003;  107 68-73
• 147 Mehra R, Benjamin E J, Shahar E et al.. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study.  Am J Respir Crit Care Med. 2006;  173 910-916
• 148 Marin J M, Carrizo S J, Vicente E, Agusti A G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.  Lancet. 2005;  365 1046-1053
• 149 Ip M S, Lam B, Ng M M, Lam W K, Tsang K W, Lam K S. Obstructive sleep apnea is independently associated with insulin resistance.  Am J Respir Crit Care Med. 2002;  165 670-676
• 150 Punjabi N M, Sorkin J D, Katzel L I, Goldberg A P, Schwartz A R, Smith P L. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men.  Am J Respir Crit Care Med. 2002;  165 677-682
• 151 Punjabi N M, Shahar E, Redline S, Gottlieb D J, Givelber R, Resnick H E. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study.  Am J Epidemiol. 2004;  160 521-530
• 152 Babu A R, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea.  Arch Intern Med. 2005;  165 447-452
• 153 Strohl K P, Saunders N A, Feldman N T, Hallett M. Obstructive sleep apnea in family members.  N Engl J Med. 1978;  299 969-973
• 154 Redline S, Tosteson T, Tishler P V, Carskadon M A, Millman R P. Studies in the genetics of obstructive sleep apnea: familial aggregation of symptoms associated with sleep-related breathing disturbances.  Am Rev Respir Dis. 1992;  145 440-444
• 155 Redline S, Tishler P V, Tosteson T D et al.. The familial aggregation of obstructive sleep apnea.  Am J Respir Crit Care Med. 1995;  151 682-687
• 156 Mathur R, Douglas N J. Family studies in patients with the sleep apnea-hypopnea syndrome.  Ann Intern Med. 1995;  122 174-178
• 157 Pillar G, Lavie P. Assessment of the role of inheritance in sleep apnea syndrome.  Am J Respir Crit Care Med. 1995;  151 688-691
• 158 Gislason T, Johannsson J H, Haraldsson A et al.. Familial predisposition and cosegregation analysis of adult obstructive sleep apnea and the sudden infant death syndrome.  Am J Respir Crit Care Med. 2002;  166 833-838
• 159 Schwab R J. Genetic determinants of upper airway structures that predispose to obstructive sleep apnea.  Respir Physiol Neurobiol. 2005;  147 289-298
• 160 Schwab R J, Arens R, Pack A. Sleep apnea. In: Lipson DA, van Beek EJR Functional Lung Imaging. Vol. 200: Lung Biology in Health and Disease. Boca Raton; Taylor and Francis 2005: 513-557
• 161 Horner R L, Mohiaddin R H, Lowell D G et al.. Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls.  Eur Respir J. 1989;  2 613-622
• 162 Miles P G, Vig P S, Weyant R J, Forrest T D, Rockette Jr H E. Craniofacial structure and obstructive sleep apnea syndrome: a qualitative analysis and meta-analysis of the literature.  Am J Orthod Dentofacial Orthop. 1996;  109 163-172
• 163 Lowe A A, Fleetham J A, Adachi S, Ryan C F. Cephalometric and computed tomographic predictors of obstructive sleep apnea severity.  Am J Orthod Dentofacial Orthop. 1995;  107 589-595
• 164 Guilleminault C, Partinen M, Hollman K, Powell N, Stoohs R. Familial aggregates in obstructive sleep apnea syndrome.  Chest. 1995;  107 1545-1551
• 165 Schwab R J, Pasirstein M, Pierson R et al.. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging.  Am J Respir Crit Care Med. 2003;  168 522-530
• 166 Schwab R J, Pasirstein M, Kaplan L et al.. Family aggregation of upper airway soft tissue structures in normal subjects and patients with sleep apnea.  Am J Respir Crit Care Med. 2006;  173 453-463
• 167 Bell C G, Walley A J, Froguel P. The genetics of human obesity.  Nat Rev Genet. 2005;  6 221-234
• 168 Stunkard A J, Foch T T, Hrubec Z. A twin study of human obesity.  JAMA. 1986;  256 51-54
• 169 Sorensen T I, Price R A, Stunkard A J, Schulsinger F. Genetics of obesity in adult adoptees and their biological siblings.  BMJ. 1989;  298 87-90
• 170 Borecki I B, Rice T, Perusse L, Bouchard C, Rao D C. An exploratory investigation of genetic linkage with body composition and fatness phenotypes: the Quebec Family Study.  Obes Res. 1994;  2 213-219
• 171 Borecki I B, Rice T, Perusse L, Bouchard C, Rao D C. Major gene influence on the propensity to store fat in trunk versus extremity depots: evidence from the Quebec Family Study.  Obes Res. 1995;  3 1-8
• 172 Rice T, Perusse L, Bouchard C, Rao D C. Familial clustering of abdominal visceral fat and total fat mass: the Quebec Family Study.  Obes Res. 1996;  4 253-261
• 173 Kadotani H, Kadotani T, Young T et al.. Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults.  JAMA. 2001;  285 2888-2890
• 174 Gottlieb D J, DeStefano A L, Foley D J et al.. APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study.  Neurology. 2004;  63 664-668
• 175 Foley D J, Masaki K, White L, Redline S. Relationship between apolipoprotein E epsilon4 and sleep-disordered breathing at different ages.  JAMA. 2001;  286 1447-1448
• 176 Saarelainen S, Lehtimaki T, Kallonen E, Laasonen K, Poussa T, Nieminen M M. No relation between apolipoprotein E alleles and obstructive sleep apnea.  Clin Genet. 1998;  53 147-148
• 177 Larkin E K, Patel S R, Redline S, Mignot E, Elston R C, Hallmayer J. Apolipoprotein E and obstructive sleep apnea: evaluating whether a candidate gene explains a linkage peak.  Genet Epidemiol. 2006;  30 101-110
• 178 O'Hara R, Schroder C M, Kraemer H C et al.. Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers.  Neurology. 2005;  65 642-644
• 179 Sakai K, Takada T, Nakayama H et al.. Serotonin-2A and 2C receptor gene polymorphisms in Japanese patients with obstructive sleep apnea.  Intern Med. 2005;  44 928-933
• 180 Riha R L, Brander P, Vennelle M et al.. Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome.  Eur Respir J. 2005;  26 673-678
• 181 Vgontzas A N, Zoumakis E, Lin H M, Bixler E O, Trakada G, Chrousos G P. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist.  J Clin Endocrinol Metab. 2004;  89 4409-4413
• 182 Palmer L J, Buxbaum S G, Larkin E et al.. A whole-genome scan for obstructive sleep apnea and obesity.  Am J Hum Genet. 2003;  72 340-350
• 183 Palmer L J, Buxbaum S G, Larkin E K et al.. Whole genome scan for obstructive sleep apnea and obesity in African-American families.  Am J Respir Crit Care Med. 2004;  169 1314-1321
• 184 Buxbaum S G, Elston R C, Tishler P V, Redline S. Genetics of the apnea hypopnea index in Caucasians and African Americans: I. Segregation analysis.  Genet Epidemiol. 2002;  22 243-253
• 185 Ginsburg G S, Donahue M P, Newby L K. Prospects for personalized cardiovascular medicine: the impact of genomics.  J Am Coll Cardiol. 2005;  46 1615-1627